I think it's early days. I mean, the announcements a couple of days old on paper, if you look at the market reaction, it's been pretty subdued as we've all been talking about this morning. I think part of that is because some of the outcome that we've saw over the last few days was probably priced in the bond markets.So we haven't seen much of a reaction there. And if you talk to most of the corporates that we're dealing with, the reality is over the course of the last year or so, the instability and the vo ...

Core Viewpoint - The recent Japanese House of Representatives election resulted in a majority for the ruling coalition of the Liberal Democratic Party and the Japan Innovation Party, leading to a significant rise in the stock market and a historical high for the Nikkei 225 index, which surpassed 57,000 points for the first time [3][5][6]. Market Reaction - Following the election results, the Nikkei 225 index increased by 5.6% to 57,337 points, while the TOPIX index rose over 3%, reaching a new historical high [5]. - The real estate sector led the gains in the Nikkei index with an increase of over 7%, followed by healthcare and industrial sectors [6]. Economic Policy Implications - Analysts suggest that the election outcome may shift the government's focus from "old high market trading" characterized by fiscal expansion and a weak yen to "new high market trading" emphasizing structural and regulatory reforms [3][6]. - The success of the ruling coalition is viewed as a potential catalyst for strategic investments and tax reforms that could further boost the Japanese stock market [6]. Currency and Bond Market Dynamics - The yen has faced significant depreciation, dropping approximately 6% against the dollar and reaching a two-week low of 157.95 [8]. - The yield on 10-year Japanese government bonds rose nearly 4 basis points to 2.274%, indicating market concerns over Japan's fiscal sustainability [8][9]. Investment Sentiment - Investment professionals express a continued interest in Japanese assets, particularly in sectors like defense, artificial intelligence, and semiconductors, which are expected to benefit from increased government spending [7][9]. - Despite the negative outlook for the yen, there is a belief that if Japan's economy continues to grow, the currency may stabilize within a certain range [9]. Future Outlook - The election results are likely to increase the probability of the dollar-yen exchange rate moving from the previous range of 155-160 to 160-165 [10]. - Market participants are cautious about potential currency interventions by Japanese authorities, especially as the yen approaches critical levels that have previously triggered intervention [10].

Group 1 - The analysis from Nomura Securities indicates that rising US Treasury yields and a weak yen will compel the Kishida administration to shift its policy focus from "old Kishida trade" of fiscal expansion and a weak yen to "new Kishida trade" emphasizing structural and regulatory reforms [1][5] - Following the recent elections, the ruling coalition of the Liberal Democratic Party and Nippon Ishin gained a majority, leading to a significant rise in the Nikkei 225 index, which surpassed 57,000 points for the first time in history [3][4] - The real estate sector led the gains in the Nikkei index, with a rise of over 7%, while companies like CyberAgent Inc. and Advantest saw substantial stock price increases of over 16% and 12%, respectively [3][4] Group 2 - Investment institutions are optimistic about sectors such as defense, artificial intelligence, and semiconductors, which are expected to benefit significantly from Kishida's increased investments in these areas [5][6] - The yen has faced significant depreciation, dropping approximately 6% against the dollar and reaching historical lows against the euro and Swiss franc, which has raised concerns about potential currency intervention [5][7] - Analysts express skepticism about Japanese government bonds, particularly long-term bonds, due to fiscal concerns, although recent yield increases have made them more attractive to some investors [5][6][7]

来源：滚动播报 美联储米兰：若不进行监管改革，就无法削减资产负债表规模。 ...

Core Viewpoint - Deutsche Bank analyzes that if Jerome Powell is elected as the Federal Reserve Chairman, his policy stance may present a unique combination of "simultaneous rate cuts and balance sheet reduction" [1] Group 1 - Deutsche Bank believes that the implementation of "simultaneous rate cuts and balance sheet reduction" is contingent upon regulatory reforms that lower banks' reserve requirements, with short-term feasibility being questionable [1] - The market needs to closely monitor whether the new Chairman can maintain independence under pressure from Trump for significant rate cuts, as well as the process of establishing his policy credibility [1]

Investment Rating - The report does not explicitly provide an investment rating for the industry Core Insights - 2026 is expected to be a year focused on growth and competitiveness, with UK and EU regulators simplifying rules to alleviate compliance burdens and promote growth agendas [3] - There may be further regulatory divergence as different policy objectives become clearer, particularly in areas like payments and cryptocurrencies [4] - The Financial Conduct Authority (FCA) is emphasizing responsible risk-taking and adapting to managed risks to support growth, with developments expected in consumer duty frameworks and housing affordability rules [7] - The introduction of new regulatory frameworks is anticipated to support consumer activities, including the finalization of "buy now, pay later" (BNPL) rules [8] - Global focus is shifting from strict green finance to transformation and adaptation, with EU regulations aiming to simplify sustainability reporting [10][14] - The EU's anti-money laundering (AML) reforms will drive compliance changes in 2026, with the FCA becoming the unified AML regulator in the UK [12] - The FCA is expected to lead in market innovation, particularly with the development of the new PISCES market and preparations for the T+1 settlement cycle [22] Summary by Sections Regulatory Developments - UK and EU regulators are working on simplifying rules to reduce compliance burdens and promote growth [3] - The FCA is focusing on responsible risk-taking and consumer education, with ongoing simplification of consumer duty frameworks [7] - New regulatory frameworks are expected to support consumer activities, including the introduction of BNPL rules [8] ESG and Sustainability - The global focus is shifting towards transformation and adaptation in ESG, with the EU working on simplifying sustainability reporting [10][14] - The EU's SFDR 2.0 aims to reduce administrative burdens while enhancing consumer clarity [10] Anti-Money Laundering - The EU's AML reforms will significantly impact compliance changes in 2026, with the FCA becoming the unified AML regulator in the UK [12] Market Innovations - The FCA is expected to lead in market innovation, particularly with the development of the new PISCES market and preparations for the T+1 settlement cycle [22] - The UK is awaiting policy positions on payment regulations, with a focus on integrating payment and electronic money systems [21]

Market Overview - The Hang Seng Index rose by 239 points or 0.9%, closing at 26,848 points, marking a three-day increase totaling 699 points or 2.67% [3] - The total market turnover was 315.19 billion, with a net inflow of 1.296 billion from northbound trading [3] Company News - Kuaishou plans to issue USD and RMB senior notes, with net proceeds intended for general corporate purposes; specific terms are yet to be determined [10] - Vanke Enterprises is convening a bondholder meeting to discuss adjustments related to the repayment of its housing rental special corporate bonds [11] - JD Logistics announced plans to acquire the remaining shares of Deppon Logistics at a price of 19 RMB per share, leading to Deppon's delisting from the Shanghai Stock Exchange [12] - Zhixing Technology has been selected as a supplier for advanced driving assistance solutions by a South Korean automotive group, with expected sales reaching one million units over the lifecycle of four models from 2026 to 2033 [13] Industry Dynamics - A report by UOB and the Hong Kong Trade Development Council indicates that 73% of surveyed enterprises in the Greater Bay Area plan to accelerate their business development in ASEAN markets, highlighting the increasing importance of ASEAN as a growth engine amid global trade tensions [8]

Core Viewpoint - The innovation in the pharmaceutical industry is a long and challenging process that brings significant returns for patients and societal development, with Zhejiang province focusing on regulatory reforms to enhance high-quality development in the sector [1]. Policy Empowerment: Releasing Financial Benefits - Regulatory reforms in Zhejiang aim to reduce institutional transaction costs for enterprises, thereby alleviating development burdens and broadening growth prospects [3]. - From January to September 2025, the biopharmaceutical and medical device industry cluster in Zhejiang achieved a revenue of 236.43 billion yuan and a total profit of 30.52 billion yuan, with a profit growth of 4.4% year-on-year, ranking second in profit margin among 12 industry clusters in the province [3]. - The implementation of significant policies, such as the "14th Five-Year Plan" and the "35 Drug Policies," has created a comprehensive policy ecosystem for innovation [3]. Continuous Release of Benefits in Reform Areas - Reforms have led to a 77% acceleration in the review time for supplementary applications, a nearly 30% reduction in provincial enterprise inspections, and over 90% paperless administrative approval rates [4]. - Various pilot reforms, including optimized review and approval processes for drug applications and production licenses, have accelerated innovation in Zhejiang's pharmaceutical companies [4]. Service Support: Streamlining Result Transformation - The Zhejiang Provincial Drug Administration provides comprehensive support to companies in the innovation process, facilitating communication and problem-solving [7]. - During the "14th Five-Year Plan" period, Zhejiang approved 22 innovative drugs and achieved breakthroughs in traditional Chinese medicine [7]. Technical Support: Establishing a Comprehensive Network - Zhejiang has established six municipal and county-level pharmaceutical innovation and review service institutions, along with 32 flexible review service stations, creating a technical support network across the province [9]. - The Zhejiang Provincial Food and Drug Inspection Research Institute has set up drug registration inspection laboratories, speeding up registration inspection timelines by 50% [9]. Localized Support for Enterprises - Local service centers are effectively addressing the needs of enterprises by integrating resources for registration consultation and review guidance, significantly increasing the number of drug registration checks since 2025 [10]. - The Zhejiang Drug Administration is committed to continuous regulatory reforms to ensure the pharmaceutical industry becomes a key driver of high-quality development in the province [10].

Group 1 - International gold prices have surged to a new high, reaching 3859.9 USD per ounce, driven by factors such as Federal Reserve policy signals, geopolitical tensions, and U.S. economic data [11][14] - The Nasdaq China Golden Dragon Index rose by over 2%, with notable gains in Chinese stocks such as Xunlei, which increased by 9.14%, and other companies like Pony.ai, Bilibili, and Alibaba showing significant upward movements [7][10] - Major U.S. stock indices experienced slight increases, with the Dow Jones up 0.15% to 46316.07 points, the S&P 500 up 0.26% to 6661.21 points, and the Nasdaq Composite up 0.48% to 22591.15 points [4][5] Group 2 - The U.S. SEC Chairman has indicated a move towards reducing regulatory burdens by potentially eliminating the requirement for companies to publish quarterly financial reports, shifting to a semi-annual reporting system instead [21][23] - President Trump has proposed imposing a 100% tariff on films produced outside the U.S., claiming that the American film industry is being undermined by foreign productions [18][19] - The international oil prices have dropped, with NYMEX WTI crude oil falling by 2.85%, influenced by the resumption of oil exports from Iraq to Turkey [16]

Core Insights - King Faisal Specialist Hospital and Research Centre (KFSHRC) will participate in the C3 Davos of Healthcare™ summit in Japan on September 24, 2025, focusing on international collaboration in healthcare [1][2] - KFSHRC's CEO, Dr. Majid Alfayyadh, will deliver a keynote speech on the vision for integrated healthcare and investment in modern medical infrastructure in Saudi Arabia [1] - KFSHRC has been recognized as the top academic medical center in the Middle East and Africa and ranked 20th globally according to the 2024 Brand Finance rankings [3] Group 1 - The summit theme is "Trilateral Cooperation: Bridging Borders in Healthcare," aimed at fostering international dialogue and collaboration among global leaders, policymakers, investors, and innovators [1] - Dr. Alfayyadh will discuss Saudi Arabia's strategy for building a patient-centered healthcare ecosystem, emphasizing digital health, hospital expansion, and medical education initiatives [1][2] - The participation of KFSHRC signifies a new chapter in its global engagement, aligning with its mission to promote medical excellence and elevate Saudi Arabia's healthcare sector to a world-leading level [2] Group 2 - KFSHRC's thought leaders will engage in strategic discussions on healthcare transformation, including opportunities for collaboration in biotechnology, robotics, and elderly care [2] - The Assistant CEO, Dr. Osama AlSwailem, will focus on integrating healthcare data and genomics into AI models for rare disease identification, highlighting advancements in data science and precision medicine [2] - KFSHRC's participation in the summit aims to strengthen global alliances dedicated to accelerating innovation and improving health outcomes across borders [2]